Nutrien Ltd. (NYSE:NTR) Shares Sold by Altshuler Shaham Ltd

Altshuler Shaham Ltd reduced its position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) by 44.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 823,074 shares of the company's stock after selling 655,000 shares during the quarter. Nutrien comprises about 1.2% of Altshuler Shaham Ltd's portfolio, making the stock its 15th biggest position. Altshuler Shaham Ltd owned approximately 0.17% of Nutrien worth $36,833,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Orion Portfolio Solutions LLC purchased a new position in Nutrien in the third quarter valued at approximately $200,000. Geode Capital Management LLC boosted its holdings in shares of Nutrien by 9.4% during the third quarter. Geode Capital Management LLC now owns 2,319,603 shares of the company's stock worth $112,454,000 after purchasing an additional 198,620 shares during the period. Virtu Financial LLC purchased a new position in shares of Nutrien during the third quarter valued at approximately $815,000. Wilmington Savings Fund Society FSB bought a new stake in Nutrien in the third quarter valued at $2,237,000. Finally, Syntax Research Inc. lifted its position in shares of Nutrien by 11.4% in the 3rd quarter. Syntax Research Inc. now owns 64,836 shares of the company's stock worth $3,116,000 after purchasing an additional 6,637 shares during the period. Institutional investors and hedge funds own 63.10% of the company's stock.

Nutrien Price Performance

Shares of NTR stock traded up $0.89 during mid-day trading on Tuesday, hitting $53.45. 319,920 shares of the stock were exchanged, compared to its average volume of 2,430,859. The company has a market cap of $26.13 billion, a PE ratio of 39.02, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77. Nutrien Ltd. has a 52-week low of $43.69 and a 52-week high of $60.87. The company has a quick ratio of 0.82, a current ratio of 1.27 and a debt-to-equity ratio of 0.38. The firm has a fifty day moving average of $50.92 and a 200 day moving average of $49.27.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). Nutrien had a net margin of 2.62% and a return on equity of 6.81%. The company had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. Research analysts anticipate that Nutrien Ltd. will post 3.72 earnings per share for the current year.

Nutrien Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, April 10th. Stockholders of record on Monday, March 31st were given a $0.545 dividend. The ex-dividend date was Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a dividend yield of 4.08%. Nutrien's dividend payout ratio (DPR) is presently 159.12%.

Analyst Ratings Changes

NTR has been the subject of a number of research reports. JPMorgan Chase & Co. upgraded Nutrien from an "underweight" rating to a "neutral" rating and increased their price objective for the stock from $40.00 to $50.00 in a report on Monday, January 13th. Berenberg Bank boosted their target price on Nutrien from $54.00 to $59.00 and gave the stock a "buy" rating in a research report on Tuesday, April 15th. Scotiabank boosted their price objective on shares of Nutrien from $60.00 to $62.00 and gave the company a "sector outperform" rating in a report on Monday, February 24th. Wells Fargo & Company boosted their price target on Nutrien from $53.00 to $56.00 and gave the company an "equal weight" rating in a research note on Friday, February 21st. Finally, Oppenheimer cut their price objective on shares of Nutrien from $60.00 to $58.00 and set an "outperform" rating for the company in a research report on Tuesday. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Nutrien currently has a consensus rating of "Moderate Buy" and an average price target of $59.27.

Nutrien Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.